ES2123269T3 - Receptores del factor 2 de liberacion de corticotropina. - Google Patents

Receptores del factor 2 de liberacion de corticotropina.

Info

Publication number
ES2123269T3
ES2123269T3 ES95925271T ES95925271T ES2123269T3 ES 2123269 T3 ES2123269 T3 ES 2123269T3 ES 95925271 T ES95925271 T ES 95925271T ES 95925271 T ES95925271 T ES 95925271T ES 2123269 T3 ES2123269 T3 ES 2123269T3
Authority
ES
Spain
Prior art keywords
receptors
release factor
corticotropin release
corticotropin
crf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95925271T
Other languages
English (en)
Other versions
ES2123269T5 (es
Inventor
Derek Chalmers
Timothy W Lovenberg
Tilman Oltersdorf
Chen Wang Liaw
Dimitri E Grigoriadis
Souza Errol B De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurocrine Biosciences Inc
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27401275&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2123269(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/381,433 external-priority patent/US5786203A/en
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of ES2123269T3 publication Critical patent/ES2123269T3/es
Application granted granted Critical
Publication of ES2123269T5 publication Critical patent/ES2123269T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA MOLECULAS DE ACIDO NUCLEICO AISLADAS QUE CODIFICAN RECEPTORES CRF{SUB,2}, VECTORES DE EXPRESION RECOMBINANTES Y CELULAS HUESPED ADECUADAS PARA EXPRESAR TALES RECEPTORES, ASI COMO COMPOSICIONES Y METODOS QUE UTILIZAN TALES RECEPTORES.
ES95925271T 1994-06-14 1995-06-14 Receptores del factor 2 de liberacion de corticotropina. Expired - Lifetime ES2123269T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25995994A 1994-06-14 1994-06-14
US08/381,433 US5786203A (en) 1994-06-14 1995-01-31 Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
US48598495A 1995-06-07 1995-06-07

Publications (2)

Publication Number Publication Date
ES2123269T3 true ES2123269T3 (es) 1999-01-01
ES2123269T5 ES2123269T5 (es) 2002-11-01

Family

ID=27401275

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95925271T Expired - Lifetime ES2123269T5 (es) 1994-06-14 1995-06-14 Receptores del factor 2 de liberacion de corticotropina.

Country Status (10)

Country Link
US (2) US6723841B2 (es)
EP (1) EP0724637B2 (es)
JP (1) JPH10501420A (es)
AT (1) ATE171212T1 (es)
AU (1) AU703140B2 (es)
CA (1) CA2193072A1 (es)
DE (1) DE69504808T3 (es)
DK (1) DK0724637T4 (es)
ES (1) ES2123269T5 (es)
WO (1) WO1995034651A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232329A1 (en) * 1994-06-10 2003-12-18 Jeffrey R. De Wet Novel human crh receptor-related receptor
US6214797B1 (en) 1995-06-13 2001-04-10 The Salk Institute For Biological Studies Urocortin peptides, nucleic acid encoding same methods for using same
AU6277796A (en) * 1995-06-13 1997-01-15 Salk Institute For Biological Studies, The Urocortin peptides
US6576441B1 (en) 1995-12-06 2003-06-10 Sumitomo Pharmaceuticals Company, Limited Semaphorin Z and gene encoding the same
HUP9900623A3 (en) * 1996-02-28 2001-11-28 Novartis Ag Promoters from plant protoporphyrinogen oxidase genes
US5888811A (en) * 1996-05-23 1999-03-30 Dupont Pharmaceuticals Company Corticotropin-releasing hormone receptor
AU7935098A (en) * 1997-06-30 1999-01-19 Taisho Pharmaceutical Co., Ltd. Proteins capable of binding to corticotropin-releasing factor
EP1171589A1 (en) * 1999-04-15 2002-01-16 Cambridge University Technical Services Limited A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
US7674463B1 (en) * 1999-07-15 2010-03-09 Research Development Foundation Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist
KR20020092891A (ko) * 1999-07-15 2002-12-12 리서치 디벨럽먼트 파운데이션 코르티코트로핀 분비 인자 수용체 2 결핍 마우스 및 이의용도
WO2001014888A1 (en) * 1999-08-24 2001-03-01 The Regents Of The University Of California Method of identifying urotensin ii receptor antagonists
CZ2003159A3 (cs) * 2000-07-19 2004-02-18 Bristol-Myers Squibb Pharma Co. Ligand CRF2 pro kombinační terapii
JP4830079B2 (ja) * 2000-11-29 2011-12-07 国立感染症研究所長 プロテアーゼ活性の測定方法
US6670140B2 (en) 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
WO2005103690A2 (en) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
CN105388293A (zh) * 2008-12-31 2016-03-09 雅培医护站股份有限公司 用于使用核苷酸缀合物的免疫测定的方法和设备
JOP20170153A1 (ar) 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232329A1 (en) 1994-06-10 2003-12-18 Jeffrey R. De Wet Novel human crh receptor-related receptor
US5786203A (en) 1994-06-14 1998-07-28 Neurocrine Biosciences, Inc. Isolated nucleic acid encoding corticotropin-releasing factor2 receptors

Also Published As

Publication number Publication date
US6723841B2 (en) 2004-04-20
EP0724637A1 (en) 1996-08-07
AU703140B2 (en) 1999-03-18
US20040185533A1 (en) 2004-09-23
WO1995034651A2 (en) 1995-12-21
ATE171212T1 (de) 1998-10-15
ES2123269T5 (es) 2002-11-01
DK0724637T3 (da) 1999-06-14
DE69504808T2 (de) 1999-05-12
US7034118B2 (en) 2006-04-25
CA2193072A1 (en) 1995-12-21
JPH10501420A (ja) 1998-02-10
EP0724637B1 (en) 1998-09-16
AU2945595A (en) 1996-01-05
DE69504808T3 (de) 2002-12-12
US20020077468A1 (en) 2002-06-20
WO1995034651A3 (en) 1996-03-14
EP0724637B2 (en) 2002-06-05
DE69504808D1 (de) 1998-10-22
DK0724637T4 (da) 2002-09-16

Similar Documents

Publication Publication Date Title
ES2123269T5 (es) Receptores del factor 2 de liberacion de corticotropina.
ES2147553T3 (es) Vectores virales recombinantes para la expresion en unas celulas musculares.
BR9914777A (pt) Moléculas isoladas de ácido nucléico que codificam os fatores induzìveis por células t (tifs), as proteìnas codificadas e os usos das mesmas
EP0653940A4 (en) GLIALMITOGENIC FACTORS, THEIR PRODUCTION AND USE.
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
DE3477813D1 (en) Improved steel wire with high tensile strength
ES2193145T3 (es) Proteinas procoagulants quimericas.
ES2143478T3 (es) Sintesis de procolagenos y colagenos humanos en sistemas de adn de recombinacion.
ATE54167T1 (de) Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
DE69828193D1 (de) Hyaluronan synthase gen und seine verwendung
AR241796A1 (es) Procedimiento para preparar levadura klyveromyces que contienen vectores que regulan la expresion de proteina y/o capaces de la expresion de proteinas homologas o heterologas.
ES8605039A1 (es) Procedimiento para preparar una vacuna que comprende un derivado truncado, libre de una membrana de un tipo fijado a una membrana que tiene determinantes antigenicos expuestos.
DE69738483D1 (de) Polypeptide mit phytase-aktivität und sie kodierende nukleinsäuren
ES2120052T3 (es) Receptor de prostaglandina fp y dna que lo codifica.
ATE236932T1 (de) Dna kodierend für prostaglandin rezeptor ip
ATE323770T1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
ES8500218A1 (es) Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas.
BR9902814A (pt) Composição cosmética destinada ao tratamento das matérias queratìnicas e processo de tratamento não-terapêutico cosmético
DE69836823D1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
ES2074280T3 (es) Metodo para modificar el tropismo de celula, tejido o huesped de un microorganismo, microorganismos recombinantes obtenidos de este modo y su uso en medicina y medicina veterinaria.
ES2174848T3 (es) Cepas de levadura que expresan el gen de ldh lactica, y vectores utilizables para la obtencion de las citadas cepas.
FR2744730B1 (fr) Nouvelle famille de canaux potassium de mammifere, leur clonage et leur utilisation notamment pour le criblage de drogues
DE69321720D1 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
DE69832875D1 (de) Isoliertes nukleinsäuremolekül, das die tumorabstossungs-antigenvorläufer mage- c1 und mage-c2 kodiert und seine verwendung
BR9708005A (pt) C3 convertase resistente à regulação para baixo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 724637

Country of ref document: ES